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The co-occurrence of depression and obesity has significant public health implications due to their 
potentially compounding and debilitating effects. The Samoan population provides a unique op-
portunity to further investigate the relationship, a component of which may be genetic, between 
obesity and depression because of the high prevalence of obesity. The first aim of this research is 
to determine if the three genetic variants associated with depression in Europeans are associated 
with the depressive features of helplessness and hopelessness in a sample of 519 Polynesians. The 
second aim is to determine if there is an association between the three genetic variants and BMI. 
In ordinal regression of helplessness and hopelessness on age, sex, BMI, and genotype I observed 
no significant associations, except for an association between higher age and higher reported hope-
lessness. In linear regression of BMI on age, sex, and genotype I observed associations between 
both lower age and female sex with higher BMI. However, there were no significant associations 
between genotype and BMI. Although I did not see associations between three genetic variants 
and the depressive features of helplessness and hopelessness or BMI, additional study of genetic 
variation and depressive features and BMI could identify pleiotropy between these phenotypes. 
Association between age and hopelessness is intriguing and additional exploration to investigate 
the robustness of this association and its underlying causes could enhance awareness, prevention, 
 v 
and treatment of depression among Samoans. The lack of an observed association between these 
depressive features and body size is contrary to what is observed in most analyses and additional 
study with this population is needed to validate whether depression and obesity are decoupled in 
this context. If this decoupling is borne out in follow-up studies in this context, it would imply that 
independent strategies are needed to address obesity and depression in Samoa. Investigating fur-
ther could also inform interventions that might interrupt the bidirectional causality that occurs 
between these two noncommunicable diseases. 
 vi 
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The co-occurrence of depression and obesity has significant public health implications due 
to their potentially compounding and debilitating effects. Obesity can make daily work and life 
tasks more difficult, therefore decreasing an individual’s productivity and sense of accomplish-
ment. Prolonged feelings of inadequacy can lead to depression and further perpetuate the behaviors 
that lead to obesity, such as decreased physical activity and increased caloric intake (Simon et al. 
2008). The reverse relationship has also been observed in which depression leads to decreased 
desire to complete daily tasks, thus reducing the amount of daily physical activity an individual 
experiences, possibly leading to weight gain and eventually obesity (Milaneschi et al. 2019; Wray 
et al. 2018). Both have been linked to high healthcare use, and, when co-occurring, can result in 
longer illness and hospital stays (Robinson et al. 2016; Opel et al. 2015).  
The Samoan population provides a unique opportunity to further investigate the relation-
ship between obesity and depression as a large portion of the population has clinical obesity. The 
most recent estimates available from 2013 are that, in Samoa, 41.2% of men and 65.1% of women 
(Lin et al. 2017) were at or above the ethnic-specific cut-off point for having clinical obesity (body 
mass index [BMI] ≥ 32 kg/m²) (Swinburn et al. 1996). On the other hand, depression is understud-
ied in Samoa. This is concerning because, as described previously, studies have identified a bidi-
rectional relationship between depression and obesity. Having one significantly increases an indi-
vidual’s risk for developing the other (Milaneschi et al. 2019). Therefore, treating one of these 
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conditions has the potential to impact the other, but if depression is underdiagnosed in Samoa this 
potentially beneficial treatment route is lost. 
While previous studies have focused on a variety of shared biological mechanisms between 
the two conditions, I am interested in further investigating the genetic mechanisms that contribute 
to the relationship between depression and obesity. 
1.2 Depression 
Depression is characterized by the American Psychiatric Association (APA) in their Diag-
nostic and Statistical Manual of Mental Disorders (DSM-5) as, “discrete episodes of a least 2 
weeks’ duration (although most episodes last considerably longer) involving clear-cut changes in 
affect, cognition, and neurovegetative functions and inter-episode remissions” (APA, 2013). Some 
of the common symptoms associated with depression lasting over a two-week period include “de-
pressed mood for most of the day; diminished interest or pleasure in all, or almost all activities; 
significant weight loss or significant change in appetite; insomnia; fatigue; diminished ability to 
think or concentrate; and recurrent thoughts of death” (APA, 2013). In order for an individual’s 
mental status to be diagnosed as a major depressive episode, at least one of the symptoms has to 
be either a depressed mood or loss of pleasure in nearly all activities for no less than 2 weeks 
(APA, 2013). The World Health Organization (WHO) defines recurrent depressive disorder as 
having repeated depressive episodes during which a person experiences “depressed mood, loss of 
interest and enjoyment, and reduced energy leading to diminished activity for at least two weeks” 
(World Health Organization, 2020). In both the APA and WHO definitions of depression there is 
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a temporal element of two weeks, this time period is what aids in distinguishing depression from 
other, more temporary, mental disorders. 
1.2.1  Depression and Public Health 
The WHO reports that there are more than 264 million people affected worldwide by de-
pression (WHO, 2020). Depression is a major public health concern due to its association with 
disability, loss of quality of life, greater service use, substantial productivity losses, and increased 
mortality (Ormel et al. 2020). One of the areas of greatest concern is the increased risk of death by 
suicide for depressed individuals. The WHO reports that nearly 800,000 people take their life by 
suicide each year, equivalent to one person every 40 seconds (WHO, 2019). However, these fig-
ures do not capture the extent of disability in all the individuals who struggle with depression, as 
many more could be contemplating suicide or have attempted suicide but were unsuccessful and 
therefore are not reported. Death by suicide is particularly prevalent globally among 15–29-year-
olds and is the second leading cause of death among this age group (WHO, 2019). 
1.2.2  Depression Measures 
There is a wide array of depression measures currently used in clinical settings. Many of 
them target a specific age-group or population. Two commonly used instruments for assessing 
depression across the lifespan are the Beck Depression Inventory (BDI) (Beck et al. 1961) and the 
Center for Epidemiologic Studies Depression Scale (CES‑D) (Radloff 1977). The BDI is intended 
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for ages 13 to 80 and consists of twenty-one self-report items presented in a multiple-choice for-
mat. The entire inventory is estimated to take an individual ten minutes to complete (APA, 2019). 
The responses are then scored on a four-point scale to indicate the degree of severity. 
The CES‑D contains twenty self-reported items also scored on a four-point scale. However, 
unlike the BDI, the CES‑D scoring is weighted by frequency of occurrence in the past week (Smarr 
& Keefer 2011). With the CES‑D, an individual rates each prompt from 0 to 3 based on the fre-
quency of the symptom experienced in the last week. A rating of 0 is “less than 1 day,” and a rating 
of 3 is “5–7 days.” This results in a possible range of scores from 0 to 60, with the higher scores 
denoting a greater occurrence of depressive symptoms experienced by the individual in the past 
week. The CES‑D was designed to capture the common symptoms of: “depressed mood, feelings 
of guilt and worthlessness, feelings of helplessness and hopelessness, psychomotor retardation, 
loss of appetite, and sleep disturbance” (Radloff 1977). 
The CES‑D is publicly available for access at no cost; whereas the BDI must be purchased 
through Pearson Assessments (Smarr & Keefer 2011). Due to the accessibility of the CES‑D and 
its validation in several distinct populations, the proxy features for depression that I used in this 
study were selected based on their similarity to statements found in the CES‑D.  
1.2.3  Depression Etiology 
The etiology of depression is influenced by many interrelated factors. From the standpoint 
of biochemistry, the focus is three major monoamines—serotonin, norepinephrine, and dopa-
mine—and the molecules that interact with them (Saveanu & Nemeroff 2012). These three mon-
oamines, as neurotransmitters, are thought to play major roles in the occurrence and severity of 
depression. Through autopsies conducted on individuals who were depressed and suicidal, it has 
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been found that those individuals had low concentrations of serotonin and norepinephrine metab-
olites in their cerebrospinal fluid (Saveanu & Nemeroff 2012). Several postmortem studies of de-
pressed individuals also revealed a decrease in dopamine transporter binding and increased 
postsynaptic dopamine receptor D₂/D₃ binding, leading to reduced dopamine neurotransmission 
(Saveanu & Nemeroff 2012). Many of the antidepressants prescribed to depressed individuals tar-
get one or more of these three monoamine neurotransmitters (Elhwuegi 2004).  
Stressful events experienced as a child and early life trauma have also been implicated as 
major contributing factors to the development of depression later in life. In a study of 1,931 
women, it was found that those who reported being abused as children were almost four times 
more likely to report having attempted suicide, more than three times more likely to report having 
been hospitalized for an emotional or mental problem, and more than twice as likely to report 
having considered suicide seven days prior to completing the questionnaire (McCauley 1997). In 
a study of 942 adults aged 65 years and greater, it was found that traumatic events experienced in 
childhood doubled an individual’s risk of late-life depression and also increased the risk of re-
peated episodes (Ritchie et al. 2009). Additionally, eight out of twenty-five negative factors were 
found to be significantly associated with late-life depression: verbal abuse from parents, mental 
cruelty, excessive punishment by parents, abuse by an adult outside the family, parental mental 
disorder, poverty, home conflict, and excessive sharing of parental problems with children (Ritchie 
et al. 2009).  
It is also thought that numerous genetic polymorphisms can affect how an individual will 
respond to stressful events encountered during their lifetime (Saveanu & Nemeroff 2012). In a 
study of 1,037 children, those who carry the short (“s”) allele at a polymorphic region linked to 
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the serotonin transporter (5‑HTT) gene (SLC6A4)—this so called 5‑HTT–linked polymorphic re-
gion is widely known as 5‑HTTLPR—showed increased susceptibility to stressful life events and 
subsequent development of depression symptoms compared to long (“l”) allele homozygotes 
(Caspi et al. 2003). 5‑HTTLPR is an ideal candidate for depression studies since the serotonin 
system is the target of many antidepressant drugs (Caspi et al. 2003). However, this region high-
lights the challenges of genetic studies of highly polygenic behavior traits like depression. Subse-
quent meta-analyses of this gene × environment effect have been mixed (Karg et al. 2011; Munafò 
et al. 2009; Risch et al. 2009; Culverhouse et al. 2018; Duncan & Keller 2011). 
Other genes of interest in the development of depression are those involved in regulation 
of the corticotropin-releasing factor and the hypothalamic-pituitary-adrenal axis (Caspi et al. 
2003). A 2008 study investigating the relationship between child abuse on adult depressive symp-
toms and genetic polymorphisms within the corticotropic-releasing hormone type 1 receptor gene 
(CRHR1) found seven of the ten tested genetic variants to have a significant interaction with child 
abuse for the prediction of adult depression (Bradley et al. 2008).  
Finally, genome-wide association studies (GWASs) of depression have also identified ge-
netic variants associated with depression. There have been 146 studies of various aspects of uni-
polar depression or treatment-resistant depression conducted to date (Buniello et al. 2019). The 
largest GWAS of depression is of participants in the UK Biobank who reported a history of seeking 
help for problems with “nerves, anxiety, tension or depression” (which the authors refer to as 
“broad depression”, n = 322,580) or who reported depressive symptoms with associated impair-
ment (which the authors refer to as “probable major depressive disorder”, n = 174,519) (Howard 
et al. 2018). The most statistically significant genetic variant associated with broad depression that 
subsequently replicated in a study of depression by 23andMe (Hyde et al. 2016) was rs6699744 
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(NC_000001.11:g.72359461A>T, with the nearest gene > 10 kbp away). I selected this variant as 
the representative of this inclusive definition of depression for analysis in this report. Two addi-
tional variants were associated and replicated with the more robust probable major depressive dis-
order phenotype: rs10929355, NM_015909.4(NBAS):c.5724+16644A>C (NC_000002.12:g.15
258840T>G), and rs5011432, NM_018374.4(TMEM106B):c.442−637A>T (NC_000007.14:g.12
229042A>T). I will also use these two variants for analysis in this report. 
1.3 Obesity 
Like depression, obesity is also considered a complex multifactorial disease (Chooi et al. 
2019). In a study of the prevalence of overweight and obesity among children and adults in 195 
countries between 1980 and 2015, it was estimated that, worldwide, 107.7 million children and 
603.7 million adults had obesity in 2015 (Afshin et al. 2017). The WHO defines overweight and 
obesity as “abnormal or excessive fat accumulation that may impair health.” The WHO classifies 
an adult as having overweight if they have a BMI ≥ 25 kg/m² and as having obesity if they possess 
a BMI ≥ 30 kg/m². Because body fat levels at a given BMI are lower in Polynesians than in Euro-
peans, Swinburn et al. (1996) proposed that for clinical and epidemiological purposes that Poly-
nesians should be considered to have overweight if they have a BMI ≥ 26 kg/m² and to have obe-
sity if they have a BMI > 32 kg/m². 
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1.3.1  Obesity and Public Health 
Obesity is a major public health concern due to the relationship between BMI and disease 
burden. High BMI is a risk factor for several chronic diseases such as cardiovascular disease, dia-
betes mellitus, chronic kidney disease, many cancers, and numerous musculoskeletal disorders. 
High BMI contributed to an estimated 4.0 million deaths among adults globally in 2015 (Afshin 
et al. 2017). The leading cause of death in 2015 that was related to high BMI, accounting for 2.7 
million deaths worldwide, was cardiovascular disease. Additionally, in 2015 high BMI accounted 
for 120 million disability-adjusted life-years lost globally (Afshin et al. 2017). Healthcare costs 
and work absences have also been correlated with the occurrence of obesity. In a cohort study of 
more than 73,000 individuals, it was found that individuals with obesity had greater medical and 
pharmacy costs, as well as a greater number of absence days and reduced productivity at work 
(Kleinman et al. 2014). 
1.3.2  Obesity Measures 
One of the most accurate methods for obesity measurement currently in use in clinical 
practice is dual-energy x-ray absorptiometry (DXA). DXA allows for differentiation between bone 
mineral content, lipid (“fat mass”), and lipid-free soft tissue (“lean mass”). From these measure-
ments the fat mass index (FMI) can be calculated by dividing an individual’s fat mass in kilograms 
by their height in meters squared. FMI is thought to be an accurate measurement for obesity be-
cause it is a direct adiposity measurement parameter and takes into account a patients’ lean mass. 
While DXA may yield better obesity measures, BMI is more accessible to a large portion 
of the world’s population due to the ease of its collection and its low cost. DXA requires a large 
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expensive machine, analysis software and an involved multi-step procedure. Whereas BMI can be 
obtained quickly with a stadiometer, a simple equation (weight in kilograms divided by the square 
of height in meters), and a calculator or smart phone. A meta-analysis of fifty-seven prospective 
studies showed that an elevated BMI increases an individual’s risk for ischemic heart disease, 
stroke, and cancers of the large intestine, kidney, endometrium and postmenopausal breast 
(MacMahon et al. 2009). BMI cut-offs for classifying an individual as having clinical obesity were 
set based on risks for cardiometabolic morbidity and premature mortality (Aune et al. 2016). Con-
cerns have been expressed that BMI and classification based on BMI does not account for ethnic 
specific muscle-to-fat ratios (Adab et al. 2018). Due to this concern, additional studies have been 
conducted and ethnic-specific cut-off points for obesity have been determined for risk assessment 
of several noncommunicable diseases (NICE, 2013). For Polynesians, the cut-off point for obesity 
has been proposed to be BMI > 32 kg/m², as they have a higher muscle-to-fat ratio than Europeans 
(Swinburn et al. 1996; Lin et al. 2017). 
1.3.3  Obesity Etiology 
Obesity is typically caused by excessive dietary intake and insufficient energy expenditure 
(Wright & Aronne 2012). There are thought to be many contributing factors to the development 
of obesity, among them: genetic, physiologic, environmental, psychological, social, and economic 
factors (Wright & Aronne 2012). Globally there has been an increase in the production and acces-
sibility of highly caloric food, while simultaneously total energy expenditure has decreased due to 
increasingly sedentary lifestyles and less physically laborious careers (Wright & Aronne 2012).  
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Numerous genetic loci have been implicated in risk of obesity, with each having an additive 
effect on the total risk (Goodarzi 2017). A 339,224-person GWAS identified 97 genome-wide sig-
nificant loci associated with BMI, accounting for 2.7% of the variation in BMI (Locke et al. 2015). 
Of these 97 loci, several gene sets were found to be related to the etiology of body size in the 
central nervous system, associated with synaptic function, long-term potentiation, and neurotrans-
mitter signaling. Other gene sets were found to be linked to integration of energy metabolism, 
polyphagia, secretion and action of insulin and related hormones, mTOR signaling, and the neu-
rotrophin signaling pathway. Obesity is a complex disease with many factors, genetic and envi-
ronmental, contributing to its development and pathology. 
 
1.4 Relationship between Obesity and Depression 
In a review conducted to explore the link between depression and obesity, it was found that 
across six meta-analyses comprised of twenty-six cross-sectional studies all identified a positive 
association between depression and obesity (Milaneschi et al. 2019). Furthermore, they discovered 
that four longitudinal meta-analyses verified the presence of a bidirectional relationship between 
obesity and depression, meaning that obesity longitudinally increases the risk of developing de-
pression, and vice versa (Milaneschi et al. 2019). Even so, not all studies report data that support 
the bidirectionality, and the relationship might be a complex one (Singh et al. 2014; Jantaratnotai 
et al. 2017). Depression is associated with a 37% higher relative risk of obesity, and obesity, with 
an 18% higher relative risk of depression (Mannan et al. 2016). Additionally, individuals with 
obesity who possess two or more chronic conditions are five times more likely to report a major 
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depressive episode in the last year (Romain et al. 2019). Among Mexican women, those who had 
obesity had 1.28 times the odds of having depression than normal-weight women (Zavala et al. 
2018). However, among Mexican men, there was no statistically significant association between 
obesity and depression (Zavala et al. 2018). This suggests that there could be sex differences in 
the relationship between obesity and depression. 
Finally, there may be genetic factors at play in the relationship between depression and 
obesity. Rivera et al. (2012) examined genetic variants in FTO—variants in which have been as-
sociated with BMI and obesity—and have observed variants that are associated with BMI in par-
ticipants with depression but not in control participants, suggesting that the effect of these variants 
is altered by the presence of depression. 
1.5 Samoa 
The Independent State of Samoa (Samoa) consists of two main islands—‘Upolu and Sa-
vai‘i—and eight small islets located in the Polynesian region of the Pacific Ocean. In 2017 the 
population of Samoa was 197,611 and is projected to reach 205,770 by 2022 (Samoa Bureau of 
Statistics, 2016). As a result of ongoing modernization, Samoa “graduated” from its status as a 
least developed country in January 2014 (UN, 2018) and is currently considered an upper-middle-
income country. As of 2016, Samoa’s gross domestic product was ranked seventh among the Oce-
anian sovereign states (CIA, 2016).  
Coupled with Samoa’s economic growth, there has also been an increase in noncommuni-
cable diseases such as cardiovascular disease, type 2 diabetes, and obesity (Hawley et al. 2012). 
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The WHO reports that 80% of all deaths in the Western Pacific Region are attributed to noncom-
municable diseases, with an estimated 452 deaths reported in 2019 in Samoa due to cardiovascular 
diseases alone (World Health Organization 2021b, 2016). A study of the trends in diabetes and 
obesity from 1978 to 2013 in Samoa, found that the increase in the prevalence of type 2 diabetes 
mellitus (31% in men and 16% in women) over the 35-year interval was attributable to increases 
in BMI (Lin et al. 2017). As obesity is a known contributing factor affecting the development and 
pathophysiology of many non-communicable diseases, the estimated 53% of men and 77% women 
in Samoa with obesity is a major public health concern (Lin et al. 2017). 
1.5.1  Death by Suicide in Samoa 
Samoa is located in the WHO defined Western Pacific Region of the world, home to an 
estimated 1.9 billion people (WHO, 2021a), about 24% of the world’s population. This region 
includes Mongolia, China, South Korea, Japan, Vietnam, Laos, Cambodia, Malaysia, Brunei, the 
Philippines, Australia, Papua New Guinea, and all of the nations and territories in Micronesia and 
Polynesia. The WHO reports that every year in the Western Pacific Region 200,000 individuals 
take their life by suicide, approximately 25% of global suicides (WHO, 2021c). In 2016, the WHO 
reported that the suicide mortality rate for males in Samoa was 6.7 per 100,000 population and 1.9 
per 100,000 population for females (WHO, 2016). While, these rates are lower than many of the 
other countries in the Western Pacific Region, Samoa it is not guaranteed to remain so, as there is 
a known association between obesity and mental health (Milaneschi et al. 2019). As obesity rates 
continue to rise in Samoa, its mental health effects should receive increasing attention. 
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1.5.2  Studying Depression in Samoa 
When studying depression it must be kept in mind that the term depression itself is a West-
ern concept (Kirmayer et al. 2017). Thus it is possible that there are presentations of depression in 
non-Western populations that fail to be captured by Western diagnostic criteria (Summerfield 
2012). Indeed, it was found that among healthcare providers in American Samoa, depression is 
rarely used and is typically not considered to be an illness (Held et al. 2010). Depression is used 
sparingly by healthcare providers in American Samoa because it is perceived that only those who 
are more educated or who comprise the younger generation would be familiar with the concept 
(Held et al. 2010). Depression, when translated to Gagana Sāmoa, is translated as “worries of the 
heart” (Held et al. 2010). This is because among Samoans “feelings” come from the loto, which is 
loosely translated as “heart,” and this is different from the heart as a physical organ. The term loto 
is a comprehensive term for “personal thoughts, feelings and volitions that is resistant to social 
conditioning” (Held et al. 2010). This nuance between the Western and Samoan interpretations of 
depression could lead to misunderstandings about whether the symptoms of depression are physi-
cal or mental and about the relationship between the two. 
Another important factor in depression is the Samoan concept of self. In a 2004 study fo-
cused on gaining greater insight into the Samoan perspectives on mental health and culturally ap-
propriate services, the research participants stressed that to assess Samoan concepts of mental 
health, you must first understand the Samoan concept of self (Tamasese et al. 2005). The Samoan 
concept of self is different from the Western individualistic concept of self in that the Samoan self 
is only seen to have meaning in relation with others. This concept of the Samoan self is so strongly 
held that when an individual seeks psychiatric services without consideration of their community 
and communal practices, they are seen as being deprived of the most valued source of meaning 
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and life support to aid in their healing process. Due to this concept of a relational self, mental 
illness is viewed as a result of fractured relations with others. 
Finally, depression is a difficult topic to study in Samoa because there is a significant 
amount of cultural stigma surrounding the topic of depression. In a 2010 study interviewing 
healthcare providers in American Samoa many expressed “that depression is taboo, embarrassing, 
or an indication that someone is crazy” (Held et al. 2010). These beliefs present obstacles for in-
dividuals seeking help for depressive symptoms and therefore make it difficult to quantify the 
number of individuals who are suffering from depression.  
1.5.3  Obesity in Samoa 
In recent years Samoa has experienced ongoing modernization, which has led to a lifestyle 
shift for many Samoans from a traditional subsistence culture to a more sedentary lifestyle (Haw-
ley et al., 2012). Coupled with this lifestyle shift and increased urbanization, there has also been a 
dietary shift toward more processed and less nutritious foods as imported prepared foods and fast 
foods become more easily accessible (Hawley et al., 2014). As a result of these changes, from 
1978–2013 the prevalence of obesity (BMI > 32 kg/m²) among men in Samoa increased from 
24.7% to 41.2%, and among women it increased from 30.0% to 65.1%  (Lin et al. 2017). 
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1.6 Specific Aims 
The goal of this project is to explore potential relationships between genetic variation as-
sociated with depression in individuals of European ancestries in among Samoan individuals and 
then assess those same variants’ relationships with body size. 
The first aim of this project is to test for association between three genetic variants previ-
ously identified as associated with depression and two proxy measurements for depression. 
The second aim is to test for association between the three depression-associated genetic 
variants and BMI. 
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2.0 Methods 
This study uses the anthropometric measurements, questionnaires, and genotyping data 
from the DNA samples previously collected by Hawley et. al (2014) and Hawley et al. (2020) to 
answer the proposed aims. This study was conducted under the auspices of the Obesity, Lifestyle 
and Genetic Adaptations (OLaGA, where ōlaga means life in Gagana Sāmoa) Study Group. 
2.1 Participants 
The dataset used for this analysis is derived from a population-based genome-wide associ-
ation study (GWAS) conducted in Samoa in 2010 with around 3,475 participants of Samoan an-
cestry (the Soifua Manuia [Good Health in Gagana Sāmoa] Study). Participants ages 24.5 to 65 
were recruited from 33 villages on both ‘Upolu and Savai‘i. Participants were excluded if they did 
not report four Samoan grandparents, were pregnant, or had physical or cognitive impairment that 
prohibited completion of study examinations. The results of this original study suggested an asso-
ciation between a novel missense variant in CREBRF and greater BMI, but lower odds of diabetes 
among Samoans (Minster et al. 2016). To further characterize this particular association, a follow-
up study was conducted between August 2017 and March 2019 which re-recruited 519 participants 
from the 24 villages on ‘Upolu and which included psychosocial instruments assessing stress and 
self-efficacy (Hawley et al. 2020). These participants were recruited based on whether they had 
consent to recontact and the presence or absence of the CREBRF variant and were excluded if they 
were pregnant, had physical or cognitive impairments, had given birth in the prior six months, 
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were currently lactating, or were or had engaged in a significant weight loss intervention (medica-
tion, survey or had lost > 5% body weight in the prior year). It is from these 519 re-recruited 
participants that the study described in this report draws its sample. 
All participants in these studies gave written informed consent with consent forms in Ga-
gana Sāmoa. The research in Samoa was reviewed and approved by the institutional review boards 
of The Miriam Hospital; Brown University; the University of Cincinnati; and the University of 
Pittsburgh. Research in Samoa was also reviewed and approved by the Health Research Committee 
of the Samoan Ministry of Health. 
2.2 Phenotypes 
Data collection consisted of two in-person interactions, one in the participant’s home and 
the other 7–10 days later in the Obesity, Lifestyle, and Genetic Adaptations (OLaGA) research 
laboratory located in the Ministry of Health building in Moto‘otua, Apia, Samoa. During the home 
visit, data were collected on height and weight and questionnaires were administered. The ques-
tionnaires were translated into Gagana Sāmoa language and administered in Gagana Sāmoa by 
local bilingual research assistants. The questionnaires collected information on individual and 
household demographic and socioeconomic characteristics, current health status and health his-
tory, physical activity, dietary intake, sleep patterns and symptoms, and psychosocial measures 
such as: body image, stress, self-efficacy, and weight control. The second in-person encounter, at 
the OLaGA research laboratory, consisted of a second measurement of height and weight, as well 
as measurement of body composition, blood pressure, and hand grip strength and biospecimen 
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collection. For the analyses in this study, I used the research lab measurements of height and 
weight. 
2.2.1  Proxy Measurements for Depression 
The CES‑D was not administered to the research participants in 2017–19 because partici-
pants identified as at high risk of clinical depression would not have access to treatment. Therefore, 
I sought to identify items in the psychosocial instruments applied to the participants that aligned 
with the questions in the CES‑D that would provide insight into associations between genetic var-
iation and risk of depression. The selected proxy measurements reflect questions found on the 
CES‑D. Two of the most common symptoms associated with depressed individuals are feelings of 
helplessness and hopelessness (Pryce et al. 2011). To capture these two feelings from the admin-
istered psychosocial instruments, I selected one question that attempted to capture the feeling of 
perceived helplessness and one that attempted to capture the feeling of hopelessness. 
The proxy measurement I selected to capture feelings of helplessness was contained in the 
self-efficacy instrument. The self-efficacy instrument consisted of 35 items aimed at assessing an 
individual’s general and social self-efficacy as well as their exercise confidence. Study participants 
were read 35 statements and for each were asked to select from the options of (1) strongly disagree 
(matua‘i fevaevaea‘i), (2) disagree (fevaevaea‘i), (3) neither agree or disagree (lē lotomalie toe lē 
fevaevaea‘i), (4) agree (lotomalie), and (5) strongly agree (matua‘i lotomalie). It was also noted 
when subjects refused to answer—in this study no one refused to answer. The statement I chose to 
reflect helplessness was “I do not seem capable of dealing with most problems that come up in 
life” (“ ‘Ou te iloa e lē mafai e a‘u ona fōia le tele o fa‘afītāuli o lenei ōlaga.”) 
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The proxy measurement I selected to capture feelings of hopelessness was contained in the 
stress instrument. The stress instrument consisted of 18 items aimed at assessing an individual’s 
general and social self-efficacy as well as their exercise confidence. The study participants were 
read 18 questions and for each were asked to select from the options of (1) never (e le‘i tupu lava), 
(2) almost never (toeitiiti lava), (3) sometimes (nisi o taimi), (4) fairly often (seāseā tupu), and 
(5) very often (tupu so‘o). The question I chose to reflect hopelessness was “In the last month, how 
often have you felt difficulties were piling up so high that you could not overcome them?” (“ ‘Ua 
iai se taimi ‘ua lagona ai ‘ua tele ni fa‘afītāuli ‘ae ‘ua lē mafai ona e fōia, i le māsina ‘ua te‘a?”) 
2.3 Genotypes 
rs5011432, rs6699744, and rs10929355, my genetic variants of interest from Howard et al. 
(2018), were not directly genotyped in the Soifua Manuia Study. However, these variants were 
observed in whole-genome sequences generated for Soifua Manuia participants sequenced as part 
of the Trans-Omics in Precision Medicine Program (Taliun et al. 2021). Unfortunately, these gen-
otypes and genotypes imputed based on them were not available at the time for this report, so 
genetic variants directly genotyped in the Soifua Manuia Study that are in high linkage disequilib-
rium with rs10929355, rs5011432, and rs6699744 were selected for use as proxies in this study. 
For rs5011432, rs4721059 (NM_018374.4[TMEM106B]:c.442−1810G>A [NC_000007.
14:g.12227869G>C]) was selected as the proxy variant. The correlation between these variants in 
the Soifua Manuia Study is r ² = 0.998. 
For rs6699744, rs11581382 (NC_000001.11:g.72363664C>T) was selected as the proxy 
variant. The correlation between these variants in the Soifua Manuia Study is r ² = 0.883. 
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For rs10929355, rs2042144 (NM_015909.4(NBAS):c.5725−14506A>G [NC_000002.12:
g.15253192T>C]) was selected as the proxy variant. The correlation between these variants in the 
Soifua Manuia Study is r ² = 0.967. 
rs4721059, rs11581382, and rs2042144 were genotyped as part of Genome-Wide Human 
SNP 6.0 arrays (Affymetrix). Extensive quality control was conducted on the basis of a pipeline 
developed by Laurie et al. (2010). Additional details of sample genotyping and genotype quality 
control are described in Minster et al. (2016). 
2.4 Statistical Analyses 
Data was coded in a Microsoft Excel spreadsheet and subsequently imported into R 3.6.0 
(R Core Team 2019) for analysis. Descriptive statistics (mean, standard deviation, and range) of 
age, BMI, helplessness, and hopelessness were calculated for the sample. The mean and standard 
deviation of age and BMI and the proportion female were calculated for each of the five levels of 
helplessness and hopelessness. To test for association between rs4721059, rs11581382, and 
rs2042144 and each of helplessness and hopelessness, I performed ordinal regression with age, 
sex, and BMI as covariates. I used ordinal regression in the analyses of helpless and hopelessness 
because I did not want to assume numerical linearity for the responses to the helplessness statement 
and the hopelessness question. To test for association between rs4721059, rs11581382, and 
rs2042144 and BMI, I performed linear regression with age, sex, and BMI as covariates. In all 




3.1 Participant Demographics and Descriptive Statistics 
The study sample of 491 participants was 55% female and ranged in age from 30.7 to 72.7 
years, with a mean age of 52.2 years. The mean BMI of the participants was 35.8 kg/m². The mean 
score for helplessness was 3.31 (for which “3” meant they neither agreed nor disagreed, and “4” 
meant they agreed, that they do not seem capable of dealing with most problems), and for hope-
lessness was 2.70 (for which “2” meant that they almost never, and “3” meant that they sometimes, 
felt difficulties were piling up so high that they could not overcome them). See Table 1 for addi-
tional details of the descriptive statistics. 
 
Table 1. Select Characteristics of Sample 
 Mean ± SD Range 
Age (years) 52.2 ± 10.0 30.7–72.7 
BMI (kg/m²) 35.8 ± 7.7 20.2–76.7 
Helplessness 3.31 ± 1.3 1–5 
Hopelessness 2.70 ± 1.1 1–5 
 
The allele frequencies of the higher-risk alleles of rs4721059, rs11581382 or rs2042144 
can be found in Table 2. The allele frequencies in Samoans are those observed in the Soifua Manuia 
Study (Minster et al. 2016). The allele frequencies of East Asians, South Asians, Admixed Ameri-
cans, Europeans and Africans are those observed in the 1000 Genomes Project (Auton et al. 2015). 
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Table 2: Allele Frequencies of rs4721059, rs11581382, and rs2042144 Risk Alleles 
 Allele Samoans East Asians South Asians Americans Europeans Africans 
rs4721059 C 0.319 0.651 0.638 0.571 0.403 0.688 
rs11581382 C 0.937 0.945 0.688 0.821 0.833 0.917 
rs2042144 T 0.050 0.139 0.370 0.425 0.539 0.049 
3.2 Helplessness 
Of the 491 helplessness responses, 58% of the participants “agreed” or “strongly agreed” 
with the statement “I do not seem capable of dealing with most problems that come up in life,” 
and 33% of the participants “disagreed” or “strongly disagreed.” The remaining 9% “neither 
agreed or disagreed.” There were 28 individuals who were not asked to agree or disagree with this 
statement; the reason for this omission was not recorded. Descriptive statistics for the participants 
in each reported helplessness category can be found in Table 3. The distributions of sex, age, and 
BMI per helplessness response are shown in Figures 1, 2, and 3, respectively. 
 
Table 3. Select Characteristics of Sample Stratified by Helplessness Response 
Helplessness “I do not seem capable of dealing with most problems that come up in life” 











Total Number 52 109 46 204 80 28 
% Female 48.1 56.9 45.7 56.4 52.5 75.0 
Age (years) mean ± sd 51.9 ± 9.3 51.7 ± 10.0 55.2 ± 9.9 51.5 ± 10.2 52.5 ± 10.4 53.0 ± 8.4 












Figure 3: BMI and Helplessness 
3.3 Hopelessness 
Out of the 491 hopelessness responses 28% of the participants responded “never” or “al-
most never” to the question “In the last month, how often have you felt difficulties were piling up 
so high that you could not overcome them?” and 17% responded “fairly often” or “very often.” 
The greatest majority (54%) selected the third of the five options, “sometimes.” There were 28 
individuals who were not asked this question; the reason for this omission was not recorded. De-
scriptive statistics for the participants in each category can be found in Table 4. The distributions 
of sex, age, and BMI per helplessness response are shown in Figures 4, 5, and 6, respectively. 
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Table 4. Select Characteristics of Sample Stratified by Hopelessness Response 
Hopelessness 
“In the last month, how often have you felt difficulties were 
piling up so high that you could not overcome them?” 
 1 2 3 4 5 NA 
 Never Almost Never Sometimes Fairly Often Often  
Total Number 108 29 269 72 46 28 
% Female 47.2 62.1 54.6 56.9 61.5 75 
Age (years) mean ± sd 50.4 ± 9.8 49.7 ± 9.5 52.6 ± 10.3 53.8 ± 9.8 50.9 ± 8.4 53.0 ± 8.4 
BMI (kg/m²) mean ± sd 36.1 ± 6.3 34.8 ± 7.7 35.2 ± 7.3 37.9 ± 9.9 37.7 ± 11.1 33.8 ± 5.2 
 
 





Figure 5: Age and Hopelessness 
 
Figure 6: BMI and Hopelessness 
3.4 Association of Helplessness with Sex, Age, BMI, and Genetic Variants 
I performed ordinal regression to assess the effects of sex, age, BMI, and genotype on 
response to the statement capturing helplessness. There was no evidence of association in this 
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sample between helplessness and age, sex, BMI or rs4721059, rs11581382 or rs2042144. Table 5 
contains the regression coefficients (β) and p values for the rs4721059, rs11581382 and rs2042144 
analyses. Figures 7, 8, and 9 display the distribution of responses to the helplessness statement 
stratified by genotype for rs4721059, rs11581382, and rs2042144, respectively. 
 
Table 5. Ordinal Regression of Helplessness on Age, Sex, BMI, and Genetic Variants 
rs4721059  rs11581382  rs2042144 
Covariate β p  Covariate β p  Covariate β p 
Age  0.001 0.891  Age  0.001 0.859  Age  0.002 0.790 
Sex  0.052 0.764  Sex  0.054 0.754  Sex  0.067 0.697 
BMI  0.004 0.703  BMI  0.004 0.704  BMI  0.005 0.642 














Figure 9: Helplessness and rs2042144 
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3.5 Association of Hopelessness with Sex, Age, BMI, and Genetic Variants 
I performed ordinal regression to assess the effects of sex, age, BMI, and genotype on 
response to the question capturing hopelessness. There was no evidence of association in this sam-
ple between hopelessness and sex, BMI or rs4721059, rs11581382 or rs2042144. There was a 
statistically significant association between higher hopelessness and higher age in all these genetic 
variant analyses; the odds of being in a higher category of hopelessness is 2.5% higher per year of 
age (p < 0.005) adjusting for sex, BMI, and the genetic variant—calculated as e ᵝ. Table 6 contains 
the regression coefficients (β) and p values for the rs4721059, rs11581382, and rs2042144 anal-
yses. Figures 10, 11, and 12 display the distribution of responses to the helplessness statement 
stratified by genotype for rs4721059, rs11581382, and rs2042144, respectively. 
 
Table 6. Ordinal Regression of Hopelessness on Age, Sex, BMI, and Genetic Variants 
rs4721059  rs11581382  rs2042144 
Covariate β p  Covariate β p  Covariate β p 
Age  0.025 0.004*  Age  0.024 0.006*  Age  0.025 0.005* 
Sex  0.257 0.161   Sex  0.245 0.181   Sex  0.237 0.197  
BMI  0.015 0.196   BMI  0.016 0.081   BMI  0.016 0.194  





Figure 10: Hopelessness and rs471059 
 
 
       




       
Figure 12: Hopelessness and rs2042144 
 
3.6 Association of BMI with Sex, Age and Genetic Variants 
The distribution of BMI by age, stratified by sex, can be found in figure 13. BMI is rela-
tively consistent across age in both sexes, except for women above the age of 55 where it tends to 
be lower with higher age. The distribution of BMI, stratified by sex, can be found in figure 14. 
There are two bell-shaped and symmetric distributions, one for each sex with separate modes; 
there is a higher mean BMI in women. This feature can also be observed in figure 13, where the 








Figure 14: Distribution of BMI Stratified by Sex 
 
To further explore these observations and to assess the association of rs4721059, 
rs11581382 and rs2043144 with BMI, I performed linear regression of BMI on sex, age, and gen-
otype. The regression coefficients and p values can be found in Table 7 for the rs4721059, 
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rs11581382 and rs2043144 analyses. Both age and sex had statistically significant effects on BMI 
in all three analyses. BMI was approximately −0.1 kg/m² lower per year (p < 0.003) and was 
approximately 4.0 kg/m² higher in women than in men (p < 3.7 × 10⁻⁹). However, there was no 
evidence of a statistically significant association between genotype and BMI for any of the vari-
ants. The distributions of BMI stratified by genotypes for rs4721059, rs11581382, and rs2043144 
are displayed in Figures 15, 16, and 17. 
 
Table 7. Linear Regression of BMI on Sex, Age and Genetic Variants 
rs4721059  rs11581382  rs2042144 
Covariate β p  Covariate β p  Covariate β p 
Age −0.100 0.003*  Age −0.098 0.003*  Age −0.100 0.002* 
Sex  4.006 2.8 × 10⁻⁹*  Sex  3.990 3.3 × 10⁻⁹*  Sex  3.985 3.7 × 10⁻⁹* 


















In this study, I looked at three proxies for genetic variants previously associated with broad 
depression or probable major depressive disorder. I tested for association between these variants 
and two depressive features, helplessness and hopelessness, as well as with BMI. I also looked at 
the relationship between age, sex, and BMI and the two depressive features, as well as between 
age and sex, and BMI. 
I observed no significant association between the three genetic variants (rs4721059, 
rs11581382 and rs2043144) and helplessness, hopelessness, or BMI. There are several limitations 
that could have contribution to lack of the observation of an association where one might yet still 
exist. One possible explanation is that the genetic variants I selected for this study were based on 
the findings from Howard et al. (2018), who used the UK Biobank and excluded individuals who 
were not recorded as “white British.” The UK Biobank is clearly not representative of the genetics 
found on Samoa, as Samoans are indigenous Polynesian people. So, it is possible that the genetic 
variants I have selected are not appropriate for study of Samoans. 
Another possible reason for there not to have been an observed relationship is that the 
genotypes of the specific genetic variants I was interested in from Howard et al. (2018) were not 
available in the Soifua Manuia Study, and nearby highly correlated variants were used instead, 
potentially diluting the correlation between the peak Howard et al. (2018) variants’ genotypes and 
the phenotypes. 
The lack of statistical power could also be contributing to the absence of an association. 
The largest effect size among the three variants in Howard et al. (2018) was an odds-ratio of 1.009. 
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The power to detect such a small odds-ratio with just 519 participants is likely very low. Addition-
ally, the allele frequencies of all three variants, especially rs2042144 (0.050 in Samoans vs 0.539 
in Europeans) are further away from 0.500 than they are in white British individuals, which also 
contributes to lower statistical power. 
Finally, it could be that the proxy measures for depression that I selected from the ques-
tionnaires did not accurately or completely capture depression within the sample. As described 
previously, depression is a complex disorder with numerous presentations that can be specific to 
the individual and their personal experiences. Additionally, this was the first time that these psy-
chosocial instruments (questionnaires) were used in the Samoan context, so it is possible that the 
questionnaires did not capture exactly the information the researchers were hoping to acquire. 
I did observe an association between hopelessness and age, where higher age was associ-
ated with higher reported hopelessness. This is inconsistent with research that has consistently 
shown that depression is less prevalent (or not more prevalent) among in late life as compared to 
midlife (Blazer et al. 1991; Charles et al. 2001; Murrell et al. 1983). Furthermore, Alvarez et al. 
(2011) found that most symptoms of depression do not differ between early- and late-onset depres-
sion, and Grayson and Thomas (2013) did not observe any differences in clinical features between 
early- and late-onset depression. This inconsistency between the finding here and the consensus in 
the literature could reflect a spurious finding in this study or a unique feature of depressive affects 
in the Samoan context. Additional studies targeting depression and depressive symptoms more 
comprehensively could aid in understanding whether this observation is real and, if so, its cause. 
Research is also consistent in the observation that depression and obesity are often co-
morbid and the relationship between them is bidirectional (Milaneschi et al. 2019). However, in 
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this study, there was no association between the depressive features of helplessness and hopeless-
ness and BMI. This could be due to the imprecision of these two proxy assessments in truly cap-
turing depression. It is intriguing however to consider whether depression and obesity might be 
decoupled in the Samoan context. Additional research is necessary to confirm that these two dis-
eases are in fact not correlated among Samoans. 
4.1 Public Health Implications 
Although this research study did not find a significant association between an individual’s 
genotype at three depression-related variants and depressive symptoms or BMI, this does not mean 
a relationship does not, in fact, exist. I studied just three genetic variants out of many that have 
been implicated in influencing depression and BMI through various pathways and mechanisms. 
There are many more possible relationships that remain to be explored. Also, as more genetics 
research is conducted with the Samoan people, an increased understanding of genomic variants 
specific to the Samoan people and the role that they play will become clearer, uncovering more 
areas of potential research. However, given the levels of obesity present within the Samoan popu-
lation, it is vital to consider the implications of that in terms of uncaptured comorbidity with de-
pression and the effect of those conditions on quality of life. 
If, as potentially suggested by this study, depression and body size are decoupled among 
Samoans, and the bidirectional nature present in many populations has been interrupted, this could 
point to social determinants present in the population that could be acting against psychosocial 
factors that might link depression and obesity. Such factors could point to interventions that might 
decouple these disorders in other populations. 
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4.2 Further Research 
Both depression and obesity are thought to be influenced by many genetic variants as well 
as various environmental factors, making them ideal candidates for polygenic risk score estima-
tion. This would provide a score predicting the relative risk for a disease. However, to yield accu-
rate results the data used to calculate these scores needs to come from large-scale genomic studies. 
A recent study conducted by Cao et al. (2021) using polygenic risk scores for depression found 
that individuals who possessed a high genetic risk as well as what they labeled as unfavorable 
lifestyle (current smoker, unhealthy diet, moderate alcohol intake, a BMI ≥ 30 kg/m², and lack of 
physical activity) had greater than a two-fold risk of incident depression than those who had low 
genetic risk and a favorable lifestyle (Cao et al. 2021). However, this study, as with a great many 
genomic studies before it, was conducted solely on individuals of European ancestries. The limited 
number of genomic studies conducted on populations of non-European ancestries, and specifically 
Samoans, makes applying polygenic risk scores difficult because the data on their applicability 
and efficacy is simply not available. Additional genetics research is necessary in populations of 
non-European ancestry to allow for scientific advances so that extant health disparities between 
those of European ancestries and those of non-European ancestries is not further exacerbated as 
interventions based on genetic information become more prevalent. 
 39 
Bibliography 
Adab P, Pallan M, Whincup PH. 2018. Is BMI the best measure of obesity? BMJ. 360. doi: 
10.1136/bmj.k1274. 
Afshin A et al. 2017. Health effects of overweight and obesity in 195 countries over 25 years. N. 
Engl. J. Med. 377:13–27. doi: 10.1056/nejmoa1614362. 
Alvarez P, Urretavizcaya M, Benlloch L, Vallejo J, Menchón JM. 2011. Early- and late-onset 
depression in the older: no differences found within the  melancholic subtype. Int. J. 
Geriatr. Psychiatry. 26:615–621. doi: 10.1002/gps.2571. 
American Psychiatric Association. 2019. Depression Assessment Instruments. 
https://www.apa.org/depression-guideline/assessment. 
American Psychiatric Association. 2013. Diagnostic and Statistical Manual of Mental Disorders. 
American Psychiatric Association doi: 10.1176/appi.books.9780890425596. 
Aune D et al. 2016. BMI and all cause mortality: Systematic review and non-linear dose-
response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million 
participants. BMJ. 353. doi: 10.1136/bmj.i2156. 
Auton A et al. 2015. A global reference for human genetic variation. Nature. 526:68–74. doi: 
10.1038/nature15393. 
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. 1961. An inventory for measuring 
depression. Arch. Gen. Psychiatry. 4:561–571. doi: 
10.1001/archpsyc.1961.01710120031004. 
Blazer D, Burchett B, Service C, George LK. 1991. The association of age and depression 
among the elderly: an epidemiologic  exploration. J. Gerontol. 46:M210-5. doi: 
10.1093/geronj/46.6.m210. 
Bradley RG et al. 2008. Influence of child abuse on adult depression: Moderation by the 
corticotropin-releasing hormone receptor gene. Arch. Gen. Psychiatry. 65:190–200. doi: 
10.1001/archgenpsychiatry.2007.26. 
Buniello A et al. 2019. The NHGRI-EBI GWAS Catalog of published genome-wide association 
studies, targeted  arrays and summary statistics 2019. Nucleic Acids Res. 47:D1005–
D1012. doi: 10.1093/nar/gky1120. 
Cao Z et al. 2021. Polygenic risk score, healthy lifestyles, and risk of incident depression. Transl. 
Psychiatry. 11:189. doi: 10.1038/s41398-021-01306-w. 
Caspi A et al. 2003. Influence of life stress on depression: Moderation by a polymorphism in the 
 40 
5-HTT gene. Science (80-. ). 301:386–389. doi: 10.1126/science.1083968. 
Central Intelligence Agency. 2016. Country Comparison: GDP (purchasing power parity). World 
Factb. https://www.cia.gov/the-world-factbook/field/real-gdp-purchasing-power-
parity/country-comparison. 
Charles ST, Reynolds CA, Gatz M. 2001. Age-related differences and change in positive and 
negative affect over 23 years. J. Pers. Soc. Psychol. 80:136–151. 
Chooi YC, Ding C, Magkos F. 2019. The epidemiology of obesity. Metabolism. 92:6–10. doi: 
10.1016/j.metabol.2018.09.005. 
Culverhouse RC et al. 2018. Collaborative meta-analysis finds no evidence of a strong 
interaction between stress  and 5-HTTLPR genotype contributing to the development of 
depression. Mol. Psychiatry. 23:133–142. doi: 10.1038/mp.2017.44. 
Duncan LE, Keller MC. 2011. A critical review of the first 10 years of candidate gene-by-
environment interaction  research in psychiatry. Am. J. Psychiatry. 168:1041–1049. doi: 
10.1176/appi.ajp.2011.11020191. 
Elhwuegi AS. 2004. Central monoamines and their role in major depression. Prog. Neuro-
Psychopharmacology Biol. Psychiatry. 28:435–451. doi: 10.1016/j.pnpbp.2003.11.018. 
Goodarzi MO. 2017. Series Obesity 1 Genetics of obesity: what genetic association studies have 
taught us about the biology of obesity and its complications. LANCET Diabetes 
Endocrinol. doi: 10.1016/S2213-8587(17)30200-0. 
Grayson L, Thomas A. 2013. A systematic review comparing clinical features in early age at 
onset and late age  at onset late-life depression. J. Affect. Disord. 150:161–170. doi: 
10.1016/j.jad.2013.03.021. 
Hawley NL et al. 2020. Exploring the paradoxical relationship of a Creb 3 regulatory factor 
missense variant with body mass index and diabetes among Samoans: Protocol for the 
Soifua Manuia (Good Health) Observational Cohort Study. JMIR Res. Protoc. 9:e17329. 
doi: 10.2196/17329. 
Hawley NL et al. 2012. Modernization and cardiometabolic risk in Samoan adolescents. Am. J. 
Hum. Biol. 24:551–557. doi: 10.1002/ajhb.22269. 
Hawley NL et al. 2014. Prevalence of adiposity and associated cardiometabolic risk factors in the 
samoan genome-wide association study. Am. J. Hum. Biol. 26:491–501. doi: 
10.1002/ajhb.22553. 
Held RF et al. 2010. Patient and health care provider views of depressive symptoms and diabetes 
in American Samoa. Cult. Divers. Ethn. Minor. Psychol. 16:461–467. doi: 
10.1037/a0020089. 
Howard DM et al. 2018. Genome-wide association study of depression phenotypes in UK 
 41 
Biobank identifies variants in excitatory synaptic pathways. Nat. Commun. 9:1470. doi: 
10.1038/s41467-018-03819-3. 
Hyde CL et al. 2016. Identification of 15 genetic loci associated with risk of major depression in  
individuals of European descent. Nat. Genet. 48:1031–1036. doi: 10.1038/ng.3623. 
Jantaratnotai N, Mosikanon K, Lee Y, McIntyre RS. 2017. The interface of depression and 
obesity. Obes. Res. Clin. Pract. 11:1–10. doi: 10.1016/j.orcp.2016.07.003. 
Karg K, Burmeister M, Shedden K, Sen S. 2011. The serotonin transporter promoter variant (5-
HTTLPR), stress, and depression  meta-analysis revisited: evidence of genetic 
moderation. Arch. Gen. Psychiatry. 68:444–454. doi: 
10.1001/archgenpsychiatry.2010.189. 
Kirmayer LJ, Gomez-Carrillo A, Veissière S. 2017. Culture and depression in global mental 
health: An ecosocial approach to the phenomenology of psychiatric disorders. Soc. Sci. 
Med. 183:163–168. doi: 10.1016/j.socscimed.2017.04.034. 
Kleinman N, Abouzaid S, Andersen L, Wang Z, Powers A. 2014. Cohort Analysis Assessing 
Medical and Nonmedical Cost Associated With Obesity in the Workplace. J. Occup. 
Environ. Med. 56:161–170. doi: 10.1097/JOM.0000000000000099. 
Laurie CC et al. 2010. Quality control and quality assurance in genotypic data for genome-wide 
association studies. Genet. Epidemiol. 34:591–602. doi: 10.1002/gepi.20516. 
Lin S et al. 2017. Trends in diabetes and obesity in Samoa over 35 years, 1978–2013. Diabet. 
Med. 34:654–661. doi: 10.1111/dme.13197. 
Locke AE et al. 2015. Genetic studies of body mass index yield new insights for obesity biology. 
Nature. 518:197–206. doi: 10.1038/nature14177. 
MacMahon S et al. 2009. Body-mass index and cause-specific mortality in 900 000 adults: 
Collaborative analyses of 57 prospective studies. Lancet. 373:1083–1096. doi: 
10.1016/S0140-6736(09)60318-4. 
Mannan M, Mamun A, Doi S, Clavarino A. 2016. Is there a bi-directional relationship between 
depression and obesity among adult  men and women? Systematic review and bias-
adjusted meta analysis. Asian J. Psychiatr. 21:51–66. doi: 10.1016/j.ajp.2015.12.008. 
McCauley J. 1997. Clinical Characteristics of Women With a History of Childhood Abuse. 
JAMA. 277:1362. doi: 10.1001/jama.1997.03540410040028. 
Milaneschi Y, Simmons WK, van Rossum EFC, Penninx BW. 2019. Depression and obesity: 
evidence of shared biological mechanisms. Mol. Psychiatry. 24:18–33. doi: 
10.1038/s41380-018-0017-5. 
Minster RL et al. 2016. A thrifty variant in CREBRF strongly influences body mass index in 
Samoans. Nat. Genet. 48:1049–1054. doi: 10.1038/ng.3620. 
 42 
Munafò MR, Durrant C, Lewis G, Flint J. 2009. Gene X environment interactions at the 
serotonin transporter locus. Biol. Psychiatry. 65:211–219. doi: 
10.1016/j.biopsych.2008.06.009. 
Murrell SA, Himmelfarb S, Wright K. 1983. Prevalence of depression and its correlates in older 
adults. Am. J. Epidemiol. 117:173–185. doi: 10.1093/oxfordjournals.aje.a113528. 
National Institute for Health and Care Excellence. 2013. BMI: Preventing Ill Health and 
Premature Death in Black, Asian and Other Minority Ethnic Groups. 
Opel N et al. 2015. Obesity and major depression: Body-mass index (BMI) is associated with a 
severe  course of disease and specific neurostructural alterations. 
Psychoneuroendocrinology. 51:219–226. doi: 10.1016/j.psyneuen.2014.10.001. 
Ormel J, Cuijpers P, Jorm A, Schoevers RA. 2020. What is needed to eradicate the depression 
epidemic, and why. Ment. Heal. Prev. 17:200177. doi: 10.1016/j.mhp.2019.200177. 
Pryce CR et al. 2011. Helplessness: a systematic translational review of theory and evidence for 
its  relevance to understanding and treating depression. Pharmacol. Ther. 132:242–267. 
doi: 10.1016/j.pharmthera.2011.06.006. 
R Core Team. 2019. R: A Language and Environment for Statistical Computing. https://www.r-
project.org/. 
Radloff LS. 1977. The CES-D scale: a self-report depression scale for research in the general 
population. Appl. Psychol. Meas. 1:385–401. doi: 10.1177/014662167700100306. 
Risch N et al. 2009. Interaction between the serotonin transporter gene (5-HTTLPR), stressful 
life  events, and risk of depression: a meta-analysis. JAMA. 301:2462–2471. doi: 
10.1001/jama.2009.878. 
Ritchie K et al. 2009. Association of adverse childhood environment and 5-HTTLPR genotype 
with late-life depression. J. Clin. Psychiatry. 70:1281–1288. doi: 10.4088/JCP.08m04510. 
Rivera M et al. 2012. Depressive disorder moderates the effect of the FTO gene on body mass 
index. Mol. Psychiatry. 17:604–611. doi: 10.1038/mp.2011.45. 
Robinson RL, Grabner M, Palli SR, Faries D, Stephenson JJ. 2016. Covariates of depression and 
high utilizers of healthcare: Impact on resource use  and costs. J. Psychosom. Res. 85:35–
43. doi: 10.1016/j.jpsychores.2016.04.002. 
Romain AJ, Marleau J, Baillot A. 2019. Association between physical multimorbidity, body 
mass index and mental health/disorders in a representative sample of people with obesity. 
J. Epidemiol. Community Health. 73:874–880. doi: 10.1136/jech-2018-211497. 
Samoa Bureau of Statistics. 2016. Population and Demography Indicator Summary. 
https://www.sbs.gov.ws/population. 
 43 
Saveanu R V., Nemeroff CB. 2012. Etiology of Depression: Genetic and Environmental Factors. 
Psychiatr. Clin. North Am. 35:51–71. doi: 10.1016/j.psc.2011.12.001. 
Simon GE et al. 2008. Association between obesity and depression in middle-aged women. Gen. 
Hosp. Psychiatry. 30:32–39. doi: 10.1016/j.genhosppsych.2007.09.001. 
Singh G, Jackson CA, Dobson A, Mishra GD. 2014. Bidirectional association between weight 
change and depression in mid-aged women: a  population-based longitudinal study. Int. J. 
Obes. (Lond). 38:591–596. doi: 10.1038/ijo.2013.127. 
Smarr KL, Keefer AL. 2011. Measures of depression and depressive symptoms: Beck 
Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale 
(CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale 
(HADS), and Patient Health Questionna. Arthritis Care Res. (Hoboken). 63:S454–S466. 
doi: 10.1002/acr.20556. 
Summerfield D. 2012. Afterword: Against “global mental health”. Transcult. Psychiatry. 
49:519–530. doi: 10.1177/1363461512454701. 
Swinburn BA, Craig PL, Daniel R, Dent DP, Strauss BJ. 1996. Body composition differences 
between Polynesians and Caucasians assessed by bioelectrical impedance. Int. J. Obes. 
Relat. Metab. Disord. 20:889–94. 
Taliun D et al. 2021. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed 
Program. Nature. 590:290–299. doi: 10.1038/s41586-021-03205-y. 
Tamasese K, Peteru C, Waldegrave C, Bush A. 2005. Ole Taeao Afua, the New Morning: A 
Qualitative Investigation Into Samoan Perspectives on Mental Health and Culturally 
Appropriate Services. Aust. New Zeal. J. Psychiatry. 39:300–309. doi: 10.1080/j.1440-
1614.2005.01572.x. 
United Nations Department of Economic and Social Affairs. 2018. Least Developed Country 
Category: Samoa Profile. https://www.un.org/development/desa/dpad/least-developed-
country-category-samoa.html. 
World Health Organization. 2021a. About WHO in the Western Pacific. 
https://www.who.int/westernpacific. 
World Health Organization. 2020. Depression. https://www.who.int/health-topics/depression. 
World Health Organization. 2016. Global Health Observatory Data Repository (Western Pacific 
Region). https://www.who.int/data/gho. 
World Health Organization. 2021b. Noncommunicable diseases in Western Pacific. 
https://www.who.int/westernpacific/health-topics/noncommunicable-diseases. 
World Health Organization. 2021c. Suicide. https://www.who.int/health-topics/suicide. 
 44 
World Health Organization. 2019. Suicide in the World: Global Health Estimates. 
Wray NR et al. 2018. Genome-wide association analyses identify 44 risk variants and refine the 
genetic architecture of major depression. Nat. Genet. 50:668–681. doi: 10.1038/s41588-
018-0090-3. 
Wright SM, Aronne LJ. 2012. Causes of obesity. Abdom. Imaging. 37:730–732. doi: 
10.1007/s00261-012-9862-x. 
Zavala GA et al. 2018. Association between obesity and depressive symptoms in Mexican 
population. Soc. Psychiatry Psychiatr. Epidemiol. 53:639–646. doi: 10.1007/s00127-018-
1517-y. 
 
